Sen Cao, Lu Bai, Yuehua Zhang, Wen Li, Zheng Wu, Xing Li, Jinyue Li, Chunwang Yang, Zhiyu Wang
{"title":"Establishment an early precise diagnosis model for bone metastasis in lung cancer based on driver gene types.","authors":"Sen Cao, Lu Bai, Yuehua Zhang, Wen Li, Zheng Wu, Xing Li, Jinyue Li, Chunwang Yang, Zhiyu Wang","doi":"10.62347/UOUD9807","DOIUrl":null,"url":null,"abstract":"<p><p>Lung cancer has become the type of cancer with the highest incidence rate and the greatest threat of death worldwide. Bone is one of the common distant metastasis sites of lung cancer. Once a patient experiences bone metastasis, it will seriously affect the patient's quality of life and survival period. This study aimed to investigate the impact of driver gene mutations on the anatomical distribution patterns of BM in lung cancer and develop a prediction model for specific BM sites of lung cancer. From 2019 to 2023, we enrolled 353 lung cancer patients diagnosed with BM at our hospital. Associations between driver gene types and BM sites or timing were analyzed using chi-square. A predictive model was constructed through logistic regression, and its performance was evaluated using AUC, DCA, calibration curves, and independent cohort validation. The research found that driver gene types were significantly associated with the risk of simultaneous pelvic metastasis (P < 0.001). Logistic regression analysis identified five independent risk factors for simultaneous pelvic metastasis in lung cancer. The model demonstrated good predictive performance, with AUC values of 0.881 in the training set and 0.816 in the validation set. This study presents a novel analysis of the relationship between driver gene types and the spatio-temporal patterns of BM. Based on driver gene types, we developed an accurate nomogram model for predicting BM in lung cancer.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"16 8","pages":"3601-3619"},"PeriodicalIF":3.1000,"publicationDate":"2026-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13559397/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/UOUD9807","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Lung cancer has become the type of cancer with the highest incidence rate and the greatest threat of death worldwide. Bone is one of the common distant metastasis sites of lung cancer. Once a patient experiences bone metastasis, it will seriously affect the patient's quality of life and survival period. This study aimed to investigate the impact of driver gene mutations on the anatomical distribution patterns of BM in lung cancer and develop a prediction model for specific BM sites of lung cancer. From 2019 to 2023, we enrolled 353 lung cancer patients diagnosed with BM at our hospital. Associations between driver gene types and BM sites or timing were analyzed using chi-square. A predictive model was constructed through logistic regression, and its performance was evaluated using AUC, DCA, calibration curves, and independent cohort validation. The research found that driver gene types were significantly associated with the risk of simultaneous pelvic metastasis (P < 0.001). Logistic regression analysis identified five independent risk factors for simultaneous pelvic metastasis in lung cancer. The model demonstrated good predictive performance, with AUC values of 0.881 in the training set and 0.816 in the validation set. This study presents a novel analysis of the relationship between driver gene types and the spatio-temporal patterns of BM. Based on driver gene types, we developed an accurate nomogram model for predicting BM in lung cancer.
期刊介绍:
The American Journal of Cancer Research (AJCR) (ISSN 2156-6976), is an independent open access, online only journal to facilitate rapid dissemination of novel discoveries in basic science and treatment of cancer. It was founded by a group of scientists for cancer research and clinical academic oncologists from around the world, who are devoted to the promotion and advancement of our understanding of the cancer and its treatment. The scope of AJCR is intended to encompass that of multi-disciplinary researchers from any scientific discipline where the primary focus of the research is to increase and integrate knowledge about etiology and molecular mechanisms of carcinogenesis with the ultimate aim of advancing the cure and prevention of this increasingly devastating disease. To achieve these aims AJCR will publish review articles, original articles and new techniques in cancer research and therapy. It will also publish hypothesis, case reports and letter to the editor. Unlike most other open access online journals, AJCR will keep most of the traditional features of paper print that we are all familiar with, such as continuous volume, issue numbers, as well as continuous page numbers to retain our comfortable familiarity towards an academic journal.